未名医药(002581)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

002581 未名医药

已收盘 05-10 15:00:00

{"stockData":{"symbol":"002581","market":"SZ","secType":"STK","nameCN":"未名医药","latestPrice":13.35,"timestamp":1715324631000,"preClose":13.69,"halted":0,"volume":5506900,"delay":0,"floatShares":401000000,"shares":660000000,"eps":-0.5134,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.34,"latestTime":"05-10 15:00:00","open":13.7,"high":13.9,"low":13.33,"amount":74869200,"amplitude":0.0416,"askPrice":13.36,"askSize":51,"bidPrice":13.35,"bidSize":1,"shortable":0,"etf":0,"ttmEps":-0.5134,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1715563800000},"adr":0,"adjPreClose":13.69,"symbolType":"stock","openAndCloseTimeList":[[1715304600000,1715311800000],[1715317200000,1715324400000]],"highLimit":15.06,"lowLimit":12.32,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":659735586,"pbRate":4.41,"roa":"--","roe":"--","epsLYR":-0.5039,"committee":-0.0837,"marketValue":8807000000,"floatMarketCap":5351000000,"peRate":-26.003116,"changeRate":-0.0248,"turnoverRate":0.0137,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2024-05-13。"},"requestUrl":"/m/hq/s/002581","defaultTab":"news","newsList":[{"id":"2433266050","title":"未名医药（002581）5月6日主力资金净卖出186.30万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433266050","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2433266050?lang=zh_cn&edition=full","pubTime":"2024-05-07 09:22","pubTimestamp":1715044924,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年5月6日收盘，未名医药报收于13.72元，下跌0.58%，换手率1.87%，成交量7.5万手，成交额1.03亿元。5月6日的资金流向数据方面，主力资金净流出186.3万元，占总成交额1.81%，游资资金净流入405.84万元，占总成交额3.94%，散户资金净流出219.54万元，占总成交额2.13%。融券方面，融券卖出3600.0股，融券偿还3.35万股，融券余量13.73万股，融券余额188.34万元。未名医药主营业务：医药制造及CDMO生物医药代研发、代生产服务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050700012322.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2431807504","title":"图解未名医药一季报：第一季度单季净利润同比减28.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431807504","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2431807504?lang=zh_cn&edition=full","pubTime":"2024-04-30 09:43","pubTimestamp":1714441406,"startTime":"0","endTime":"0","summary":"证券之星消息，未名医药2024年一季报显示，公司主营收入8380.48万元，同比上升10.85%；归母净利润-2770.41万元，同比下降28.82%；扣非净利润-2833.0万元，同比下降28.2%；负债率4.56%，投资收益-674.02万元，财务费用-27.74万元，毛利率80.13%。财报数据概要请见下图: 以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024043000019382.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2431809039","title":"未名医药（002581）4月29日主力资金净买入1052.31万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431809039","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2431809039?lang=zh_cn&edition=full","pubTime":"2024-04-30 09:12","pubTimestamp":1714439521,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年4月29日收盘，未名医药报收于13.87元，上涨9.99%，涨停，换手率2.49%，成交量9.98万手，成交额1.33亿元。4月29日的资金流向数据方面，主力资金净流入1052.31万元，占总成交额7.9%，游资资金净流出1251.91万元，占总成交额9.39%，散户资金净流入199.6万元，占总成交额1.5%。融券方面，融券卖出3.02万股，融券偿还6400.0股，融券余量17.68万股，融券余额245.18万元。未名医药主营业务：医药制造及CDMO生物医药代研发、代生产服务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024043000018167.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2431805811","title":"图解未名医药年报：第四季度单季净利润同比减357.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431805811","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2431805811?lang=zh_cn&edition=full","pubTime":"2024-04-30 08:36","pubTimestamp":1714437400,"startTime":"0","endTime":"0","summary":"证券之星消息，未名医药2023年年报显示，公司主营收入4.3亿元，同比上升20.36%；归母净利润-3.32亿元，同比下降2164.66%；扣非净利润-3.18亿元，同比下降3641.28%；其中2023年第四季度，公司单季度主营收入9144.38万元，同比上升12.13%；单季度归母净利润-3.62亿元，同比下降357.69%；单季度扣非净利润-3.5亿元，同比下降409.95%；负债率6.99%，投资收益1.73亿元，财务费用733.29万元，毛利率80.6%。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024043000016211.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2431888874","title":"4月29日未名医药涨9.99%，鑫元中证1000指数增强发起式A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2431888874","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2431888874?lang=zh_cn&edition=full","pubTime":"2024-04-29 16:38","pubTimestamp":1714379880,"startTime":"0","endTime":"0","summary":"证券之星消息，4月29日未名医药涨9.99%，收盘报13.87元，换手率2.49%，成交量9.98万手，成交额1.33亿元。重仓未名医药的公募基金请见下表：根据2024基金Q1季报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为鑫元中证1000指数增强发起式A。鑫元中证1000指数增强发起式A目前规模为0.3亿元，最新净值0.9302，较上一交易日上涨1.73%，近一年下跌12.57%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042900017522.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2431479077","title":"异动快报：未名医药（002581）4月29日14点21分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2431479077","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2431479077?lang=zh_cn&edition=full","pubTime":"2024-04-29 14:25","pubTimestamp":1714371925,"startTime":"0","endTime":"0","summary":"证券之星4月29日盘中消息，14点21分未名医药触及涨停板。目前价格13.87，上涨9.99%。其所属行业生物制品目前上涨。领涨股为奥浦迈。该股为高校系，创新药，新冠病毒防治概念热股，当日高校系概念上涨2.93%，创新药概念上涨2.72%，新冠病毒防治概念上涨2.69%。4月26日的资金流向数据方面，主力资金净流出204.03万元，占总成交额4.55%，游资资金净流出40.56万元，占总成交额0.9%，散户资金净流入244.59万元，占总成交额5.46%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042900009465.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430739412","title":"ST富润、未名医药收到行政处罚事先告知书 投资者可参与索赔","url":"https://stock-news.laohu8.com/highlight/detail?id=2430739412","media":"市场资讯","top":-1,"share":"https://www.laohu8.com/m/news/2430739412?lang=zh_cn&edition=full","pubTime":"2024-04-25 09:49","pubTimestamp":1714009740,"startTime":"0","endTime":"0","summary":"　　2024年4月24日晚间，ST富润（维权）、未名医药（维权）两家上市公司发别发布关于收到中国证券监督管理委员会浙江监管局《行政处罚事先告知书》的公告和关于收到中国证券监督管理委员会《行政处罚及市场禁入事先告知书》的公告，此前两家上市公司分别于于2023年10月27日和 2023 年 11 月 21日遭证监会立案。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/gmwq/rightscase/2024-04-25/doc-inaszaue6223106.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/gmwq/rightscase/2024-04-25/doc-inaszaue6223106.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430412742","title":"未名医药，又遭监管处罚！","url":"https://stock-news.laohu8.com/highlight/detail?id=2430412742","media":"中国基金报","top":-1,"share":"https://www.laohu8.com/m/news/2430412742?lang=zh_cn&edition=full","pubTime":"2024-04-25 09:35","pubTimestamp":1714008900,"startTime":"0","endTime":"0","summary":"4月24日晚间，未名医药公告称，由于公司信息披露涉嫌违法违规，2023年11月21日被中国证监会立案。综合未名医药的上述两项信息披露违法违规行为，山东证监局拟决定对未名医药采取责令改正措施，给予警告，并处以310万元罚款；对潘爱华、罗德顺、杨晓敏等当事人给予警告，并处以相应罚款。其中，未名医药未按规定披露关联方资金往来，成为监管关注的重点。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":null,"url":"http://mp.weixin.qq.com/s?__biz=MzA5MDEzNjQwMA==&mid=2656064724&idx=3&sn=c51d645866ce8e56acd27be5a6d7de70&chksm=8a0f162b5ba9269760c591738c78cc23ab8e465178e3c6719f7e3d72fb41aa73f308dba4d983&scene=0#rd","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzA5MDEzNjQwMA==&mid=2656064724&idx=3&sn=c51d645866ce8e56acd27be5a6d7de70&chksm=8a0f162b5ba9269760c591738c78cc23ab8e465178e3c6719f7e3d72fb41aa73f308dba4d983&scene=0#rd","is_publish_highlight":false,"gpt_icon":0},{"id":"2409846971","title":"业绩预告不准确 未名医药收警示函","url":"https://stock-news.laohu8.com/highlight/detail?id=2409846971","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2409846971?lang=zh_cn&edition=full","pubTime":"2024-02-05 22:16","pubTimestamp":1707142560,"startTime":"0","endTime":"0","summary":"　　因多项信披违规，未名医药（维权）及相关人员被监管部门警示。　　2月2日晚间，未名医药公告披露，于近期收到中国证券监督管理委员会山东监管局《关于对山东未名生物医药股份有限公司及相关人员采取出具警示函措施的决定》。　　经查，未名医药未按规定披露关联方资金往来。　　除了上述事项，未名医药被警示的原因还包括“2022年度业绩预告信息披露不准确”。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2024-02-05/doc-inafzchu2900740.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2024-02-05/doc-inafzchu2900740.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2408908345","title":"业绩预告“变脸”未及时修正 未名医药收警示函","url":"https://stock-news.laohu8.com/highlight/detail?id=2408908345","media":"证券时报","top":-1,"share":"https://www.laohu8.com/m/news/2408908345?lang=zh_cn&edition=full","pubTime":"2024-02-04 07:08","pubTimestamp":1707001680,"startTime":"0","endTime":"0","summary":"　　因存在未按规定披露关联方资金往来、未按规定披露对外担保、2022年度业绩预告信息披露不准确等问题，2月2日晚间，未名医药（维权）公告近期收到山东证监局警示函。但实际年度业绩出炉却出现“变脸”。公司2022年度业绩预告与定期报告披露的净利润差异金额较大，且未及时修正。　　基于上述事实，山东证监局决定对未名医药及时任董事长潘爱华、岳家霖等采取出具警示函的行政监管措施。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/s/2024-02-04/doc-inafvnhn4654105.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/s/2024-02-04/doc-inafvnhn4654105.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2389485406","title":"未名医药(002581.SZ)：全资子公司合肥未名停产搬迁","url":"https://stock-news.laohu8.com/highlight/detail?id=2389485406","media":"市场资讯","top":-1,"share":"https://www.laohu8.com/m/news/2389485406?lang=zh_cn&edition=full","pubTime":"2023-12-08 21:25","pubTimestamp":1702041900,"startTime":"0","endTime":"0","summary":"来源：格隆汇格隆汇12月8日丨未名医药公布，为充分发挥集群效应，促进公司持续稳定健康发展，山东未名生物医药股份有限公司全资子公司北大未名(合肥)生物制药有限公司将于2023年12月8日正式停产，并搬迁至山东省淄博市张店经济开发区山东未名生物医药产业园。合肥未名核心业务主要包括生物医药代研发服务，搬迁至山东未名生物医药产业园厂区后，可进一步增强相关产品的配套效率，有利于打通上下游节点，完善产业链。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-12-08/doc-imzxiiin8019013.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-12-08/doc-imzxiiin8019013.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2385628560","title":"因信息披露涉嫌违法违规 未名医药(002581.SZ)被中国证监会立案调查","url":"https://stock-news.laohu8.com/highlight/detail?id=2385628560","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2385628560?lang=zh_cn&edition=full","pubTime":"2023-11-23 18:53","pubTimestamp":1700736780,"startTime":"0","endTime":"0","summary":"未名医药(002581.SZ)发布公告，公司于2023年11月21日收到中国证券监督管理委员会(“中国证监会”)出具的《立案告知书》(编号：证监立案字0042023010号)。因公司信息披露涉嫌违法违规，根据《中华人民共和国证券法》《中华人民共和国行政处罚法》等法律法规，中国证监会决定对公司立案。\n\n现在送您60元福利红包，直接提现不套路~~~快来参与活动吧！\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-11-23/doc-imzvreks5493324.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-11-23/doc-imzvreks5493324.shtml","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2011-05-20","address":"山东省淄博市张店区淄博科技工业园南支一路(兴园路)28号","stockEarnings":[{"period":"1week","weight":-0.0326},{"period":"1month","weight":-0.0052},{"period":"3month","weight":0.1731},{"period":"6month","weight":-0.2211},{"period":"1year","weight":-0.344},{"period":"ytd","weight":-0.0856}],"companyName":"山东未名生物医药股份有限公司","boardCode":"AI0027","perCapita":"11322股","boardName":"医药制造业","registeredCapital":"65973万元","compareEarnings":[{"period":"1week","weight":0.016},{"period":"1month","weight":0.042},{"period":"3month","weight":0.1007},{"period":"6month","weight":0.038},{"period":"1year","weight":-0.0468},{"period":"ytd","weight":0.0604}],"survey":"　　山东未名生物医药股份有限公司主营业务为为干扰素、神经生长因子、生物医药CRO/CDMO、疫苗和医药中间体等五大生物医药板块。主要产品有鼠神经生长因子、干扰素、原材料。公司子公司天津未名是我国率先进入基因工程制药产业化领域的企业之一。重点发展人干扰素α2b系列产品，主要产品捷抚-重组人干扰素α2b喷雾剂（假单胞菌），是全球第一支干扰素喷雾剂。","serverTime":1715485476252,"listedPrice":19,"stockholders":"35398人(较上一季度增加0.25%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"未名医药(002581)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供未名医药(002581)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"未名医药,002581,未名医药股票,未名医药股票老虎,未名医药股票老虎国际,未名医药行情,未名医药股票行情,未名医药股价,未名医药股市,未名医药股票价格,未名医药股票交易,未名医药股票购买,未名医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"未名医药(002581)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供未名医药(002581)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}